Table 4 Cox-regression analysis of factors associated with time to treatment change
Variable | Categories | UHR(95\(\%\)CI) | AHR(95 \(\%\)CI) | p-value |
|---|---|---|---|---|
Gender | Female | 1 | 1 | |
Male | 0.3977 (0.1512\(-\) 1.046e) | 0.5524 (0.20444 \(-\) 1.4925e) | 0.2419 | |
NNRTI | Efavirenz | 1 | 1 | |
Nevirapine | 4.926 (2.082\(-\) 11.66e) | 1.8107 (0.58091\(-\) 5.6438e) | 0.3060 | |
Backbone | Zidovudine | 1 | 1 | |
Tenofovir | 0.1693 (0.06829\(-\) 0.4198e) | 0.2682 (0.08263\(-\) 0.8706e) | 0.0285 |